Breakthrough Drug Fights Cancer's RNA
Researchers have developed a groundbreaking drug molecule, Q2-RIBOTAC, which specifically targets and eliminates TERRA, an RNA molecule crucial for the survival of aggressive cancer cells, without harming healthy tissue. This innovative "RIBOTAC" technology holds immense promise for revolutionizing cancer therapy by addressing the disease at its genetic roots and opening new avenues for treating previously intractable conditions.